Ultomiris 25682-0025-01
Generic: Ravulizumab
- Manufacturer
- Alexion Pharmaceuticals Inc.
- Dosage Form
- Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 9, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA761108
Need to source Ultomiris? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ravulizumab | 300 mg/3mL |
Drug Class
Complement Inhibitor [EPC]Complement Inhibitor [EPC]Complement Inhibitors [MoA]
Selected Package
25682-0025-01Selected1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS